Brief: CompuGroup Medical Confirms Mid-Term Ambition At Capital Markets Day
Sept 1 (Reuters) - COMPUGROUP MEDICAL SE & CO KGAA
COP1n.DE :
* COMPUGROUP MEDICAL CONFIRMS MID-TERM AMBITION AT THE
CAPITAL
MARKETS DAY
* WELL ON TRACK FOR STRONG REVENUE GROWTH IN 2022
* RECENTLY RAISED GUIDANCE FOR 2022 CONFIRMED
* ADJUSTED EBITDA MARGIN IMPROVEMENT POST INVESTMENT PHASE
TOWARDS
27 % BY 2025
Source text for Eikon: ID:nEQ7x4wsxa
Further company coverage: COP1n.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on CompuGroup Medical SE & Co KgaA
See all newsBrief: Nagarro to replace CompuGroup in Germany's TecDax, Stratec in SDAX
Brief: Compugroup Medical Delisting Effective 24 June 2025
Brief: Compugroup Medical SE & Co KGaA - Issues Joint Reasoned Statement Recommending Shareholders To Accept Cvc's Public Delisting Offer
Brief: Cvc Capital Partners - Acceptance Period For Public Delisting Offer To Shareholders Of Compugroup Begins
Brief: Caesar Bidco Says Intends To Offer Cash Consideration In Amount Of Eur 22.00 Per CompuGroup Medical Share